
IOV
Funder
8 Projects, page 1 of 2
- Uppsala University,IOV,UCC,MHH,UCL,UCD,IRCCS,USC,Roche (Switzerland),IRB,SeroS,ECAMRICERT SRL,ADVANCELL ADVANCED IN VITRO CELL TECHNOLOGIES S.A,CEA,UCL,University of Angers,SARD,SIGMOID,Veneto Nanotech (Italy)Funder: European Commission Project Code: 281035
more_vert Open Access Mandate for Publications assignment_turned_in Project2012 - 2016Partners:IOV, LMU, University of Twente, Institut Gustave Roussy, LEUKOCARE AG +7 partnersIOV,LMU,University of Twente,Institut Gustave Roussy,LEUKOCARE AG,MTA SZBK,University of Tübingen,ICR,ACZON SRL,Asper Biotech (Estonia),IRCCS,Aquamarijn (Netherlands)Funder: European Commission Project Code: 305341more_vert assignment_turned_in ProjectFrom 2017Partners:INSTITUT PASTEUR (BP), IOV, KUL, IRCCS, Istituto Zooprofilattico Sperimentale delle Venezie +1 partnersINSTITUT PASTEUR (BP),IOV,KUL,IRCCS,Istituto Zooprofilattico Sperimentale delle Venezie,HumabsFunder: French National Research Agency (ANR) Project Code: ANR-16-IFEC-0006Funder Contribution: 245,999 EURmore_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2021 - 2025Partners:RISE, UCL, Roche (Switzerland), SOCIETA ITALIANA DI FARMACIA CLINICA E TERAPIA, AZIENDA ULSS N3 SERENISSIMA +22 partnersRISE,UCL,Roche (Switzerland),SOCIETA ITALIANA DI FARMACIA CLINICA E TERAPIA,AZIENDA ULSS N3 SERENISSIMA,ELSA SCIENCE AB,University of Dundee,Lund University,REGION UPPSALA,ICU MEDICAL BV,IRCCS,UNIPD,AbbVie,BII GMBH,SWEDISH RHEUMATISM ASSOCIATION,CPI,LABBOT,SANOFI-AVENTIS DEUTSCHLAND GMBH,Lonza AG,AstraZeneca (Sweden),IOV,PFIZER,Teva Pharmaceuticals (Israel),AOUI,PLURIMA,IDIBAPS-CERCA,MERCK KOMMANDITGESELLSCHAFT AUF AKTIENFunder: European Commission Project Code: 101007939Overall Budget: 7,132,610 EURFunder Contribution: 3,139,980 EURRealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients by applying smart tag technologies. Different parameters will be logged and combined with protein characterisation at different stages, as well as with information from EFPIA partners on their drugs in use. Statistical evaluation of the data will be used to identify patterns in handling that are linked to protein destabilisation occurrence and type of protein degradation. Focus interviews with personnel in hospital pharmacies, clinics and with patients/care givers will be used to understand current handling practice and what the desired handling instructions and limitations are. These insights will be used to design in-use mimicking stability protocols for the protein drugs in the project. Ultra-scaled-down devices for stability assessment will be designed to be used in early phase for efficient development cost effective and safe future protein therapies. Protocols and devices will be validated towards the collected handling data base. Interventions in hospital pharmacies using e.g. compounding robots will be investigated. Techniques to assess e.g. aggregate formation in the final drug preparation situation will be evaluated together with SMEs producing analytical tools and hospital pharmacists. The collected data and interviews will form the base of development of teaching materials directed towards different target groups: hospital pharmacists, nurses and patients/care givers. App developers will be active in this part to design attractive and efficient apps for teaching and collecting therapy performance data.
more_vert - MPG,UNITO,IOV,TBCT,HUS,UoA,CBB,UKE,AGB,Institute Curie,Luxembourg Institute of Health,INSTITUT DE RECHERCHES SERVIER,Alacris (Germany),BII GMBH,Oslo University Hospital,SHD,Eli Lilly and Company Limited,IRCCS,QIAGEN GMBH,Bayer Pharma AG,GILUPI GMBH,GABO:mi,MSB,UM,THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE,Agilent,ANGLE,HHU,Bayer AG,Charité - University Medicine Berlin,GERMAN CANCER RESEARCH CENTER,ARTTIC,Orion Corporation (Finland),University of Twente,MUG,UMCG,University of Manchester,VyC,EORTC,LEUKOCARE AG,Institut Gustave Roussy,Tataa Biocenter (Sweden)Funder: European Commission Project Code: 115749
more_vert
chevron_left - 1
- 2
chevron_right